Literature DB >> 12646582

The direct interaction of phospholipase C-gamma 1 with phospholipase D2 is important for epidermal growth factor signaling.

Il Ho Jang1, Sukmook Lee, Jong Bae Park, Jong Hyun Kim, Chang Sup Lee, Eun-Mi Hur, Il Shin Kim, Kyong-Tai Kim, Hitoshi Yagisawa, Pann-Ghill Suh, Sung Ho Ryu.   

Abstract

The epidermal growth factor (EGF) receptor has an important role in cellular proliferation, and the enzymatic activity of phospholipase C (PLC)-gamma1 is regarded to be critical for EGF-induced mitogenesis. In this study, we report for the first time a phospholipase complex composed of PLC-gamma1 and phospholipase D2 (PLD2). PLC-gamma1 is co-immunoprecipitated with PLD2 in COS-7 cells. The results of in vitro binding analysis and co-immunoprecipitation analysis in COS-7 cells show that the Src homology (SH) 3 domain of PLC-gamma1 binds to the proline-rich motif within the Phox homology (PX) domain of PLD2. The interaction between PLC-gamma1 and PLD2 is EGF stimulation-dependent and potentiates EGF-induced inositol 1,4,5-trisphosphate (IP(3)) formation and Ca(2+) increase. Mutating Pro-145 and Pro-148 within the PX domain of PLD2 to leucines disrupts the interaction between PLC-gamma1 and PLD2 and fails to potentiate EGF-induced IP(3) formation and Ca(2+) increase. However, neither PLD2 wild type nor PLD2 mutant affects the EGF-induced tyrosine phosphorylation of PLC-gamma1. These findings suggest that, upon EGF stimulation, PLC-gamma1 directly interacts with PLD2 and this interaction is important for PLC-gamma1 activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12646582     DOI: 10.1074/jbc.M208438200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

Review 1.  The exquisite regulation of PLD2 by a wealth of interacting proteins: S6K, Grb2, Sos, WASp and Rac2 (and a surprise discovery: PLD2 is a GEF).

Authors:  Julian Gomez-Cambronero
Journal:  Cell Signal       Date:  2011-06-29       Impact factor: 4.315

Review 2.  Phospholipase C and D regulation of Src, calcium release and membrane fusion during Xenopus laevis development.

Authors:  Bradley J Stith
Journal:  Dev Biol       Date:  2015-03-05       Impact factor: 3.582

3.  Novel functions of the phospholipase D2-Phox homology domain in protein kinase Czeta activation.

Authors:  Jong Hyun Kim; Jung Hwan Kim; Motoi Ohba; Pann-Ghill Suh; Sung Ho Ryu
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

4.  The Lipase Activity of Phospholipase D2 is Responsible for Nigral Neurodegeneration in a Rat Model of Parkinson's Disease.

Authors:  Hector R Mendez-Gomez; Jasbir Singh; Craig Meyers; Weijun Chen; Oleg S Gorbatyuk; Nicholas Muzyczka
Journal:  Neuroscience       Date:  2018-03-09       Impact factor: 3.590

5.  Subcellular localization and function of alternatively spliced Noxo1 isoforms.

Authors:  Takehiko Ueyama; Kristen Lekstrom; Satoshi Tsujibe; Naoaki Saito; Thomas L Leto
Journal:  Free Radic Biol Med       Date:  2006-09-12       Impact factor: 7.376

6.  Characterization of PXK as a protein involved in epidermal growth factor receptor trafficking.

Authors:  Hiroshi Takeuchi; Takako Takeuchi; Jing Gao; Lewis C Cantley; Masato Hirata
Journal:  Mol Cell Biol       Date:  2010-01-19       Impact factor: 4.272

Review 7.  Phospholipase D in cell signaling: from a myriad of cell functions to cancer growth and metastasis.

Authors:  Julian Gomez-Cambronero
Journal:  J Biol Chem       Date:  2014-07-02       Impact factor: 5.157

8.  PLC-gamma1 and Rac1 coregulate EGF-induced cytoskeleton remodeling and cell migration.

Authors:  Siwei Li; Qian Wang; Yi Wang; Xinmei Chen; Zhixiang Wang
Journal:  Mol Endocrinol       Date:  2009-03-05

9.  IRAS Modulates Opioid Tolerance and Dependence by Regulating μ Opioid Receptor Trafficking.

Authors:  Fei Li; Hao Ma; Ning Wu; Jin Li
Journal:  Mol Neurobiol       Date:  2015-09-12       Impact factor: 5.590

Review 10.  Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer.

Authors:  Ronald C Bruntz; Craig W Lindsley; H Alex Brown
Journal:  Pharmacol Rev       Date:  2014-10       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.